slides · global inventory
List
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 110,471
Current window 71,431-71,460
Pages 3,683
Rows per page 30
Component
71,431-71,460 of 110,471
01
This is a short-seller research note cover page/executive summary.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller Beat · Setup & Stakes1 hit
06
The slide uses highly aggressive, accusatory language to frame the report's sections.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller Beat · Setup & Stakes1 hit
09
The slide uses a list-based structure to present evidence of drug toxicity, citing specific page ranges from a larger document.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller Beat · Setup & Stakes1 hit
29
The slide uses a scientific diagram to explain the mechanism while simultaneously casting doubt on the underlying theory.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller Beat · The MonsterLoop · Aha Moment1 hit
41
The slide uses a Q&A format to highlight potential corporate malfeasance regarding clinical trial adverse events.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller Beat · The Struggle1 hit
43
The slide uses a Q&A format to present qualitative evidence of internal doubt regarding clinical trial integrity.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller Beat · The Struggle1 hit
46
The slide uses legal filings and OIG reports to establish a pattern of billing abuse in the sleep sector.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller Beat · The Struggle1 hit
76
The slide uses excerpts from scientific literature to frame the technical hurdles in CNS drug development.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
85
The slide uses a Q&A format to build a case against the drug's efficacy based on metabolic pathways.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
87
The slide uses a Q&A transcript format to validate the thesis that the drug class is fundamentally flawed.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
90
The slide uses a Q&A transcript format to validate a negative thesis about the viability of H3 receptor programs.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
102
Uses Q&A format to frame expert opinion as a critique of Bioprojet's claims.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
138
The slide uses direct excerpts from the drug's prescribing information to build a case against its safety profile.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
139
The slide uses a direct excerpt from a package insert to support the argument that dose reduction is required due to drug interactions.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
141
The slide uses direct citations from peer-reviewed papers to validate the consultant's findings.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
147
The slide uses direct excerpts from FDA documents and product labels to highlight a contradiction in clinical trial methodology.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
150
The slide uses a specific calculation (153 ng/mL * 4 * 2 = 1224 ng/mL) to quantify risk.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
156
The slide uses a combination of narrative analysis and a specific case study excerpt to challenge the safety profile of pitolisant.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
164
The slide uses a combination of original analysis and cited medical literature to challenge the transparency of clinical trial reporting.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
175
The slide uses a list of adverse events to build a case for cardiotoxicity, highlighting specific fatal and serious outcomes.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
176
The slide highlights specific medical conditions and counts of adverse event reports from the FDA FAERS database.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
90
Uses Q&A format to frame the critique as an expert interview.IonQ Inc. (IONQ) · Scorpion Capital
Activist deck Short seller 1 hit
135
The slide uses direct quotes to undermine the company's value proposition.IonQ Inc. (IONQ) · Scorpion Capital
Activist deck Short seller 1 hit
149
The slide uses a 'before-after' or 'contradiction' framing to highlight the discrepancy between actual revenue and projected bookings.IonQ Inc. (IONQ) · Scorpion Capital
Activist deck Short seller Beat · The Conclusion that IonQ's Claims are Exaggerated1 hit
155
The slide uses a combination of narrative accusation and direct quotes from earnings materials to build a case of financial misrepresentation.IonQ Inc. (IONQ) · Scorpion Capital
Activist deck Short seller 1 hit
159
The slide uses a Q&A format to highlight the absurdity of the transaction size relative to actual usage capacity.IonQ Inc. (IONQ) · Scorpion Capital
Activist deck Short seller 1 hit
160
The slide uses a Q&A transcript format to highlight a discrepancy between company claims and expert testimony.IonQ Inc. (IONQ) · Scorpion Capital
Activist deck Short seller 1 hit
172
The slide uses a 'villain' framing by questioning the capacity of the subject to fulfill all stated obligations.IonQ Inc. (IONQ) · Scorpion Capital
Activist deck Short seller 1 hit
177
The slide uses direct quotes and Q&A transcripts to build a narrative of executive negligence.IonQ Inc. (IONQ) · Scorpion Capital
Activist deck Short seller 1 hit
183
Uses Q&A format to highlight lack of transparency regarding a key executive.IonQ Inc. (IONQ) · Scorpion Capital
Activist deck Short seller 1 hit